246 related articles for article (PubMed ID: 29056151)
1. The Role of Neuropeptide Y (NPY) in Alcohol and Drug Abuse Disorders.
Robinson SL; Thiele TE
Int Rev Neurobiol; 2017; 136():177-197. PubMed ID: 29056151
[TBL] [Abstract][Full Text] [Related]
2. Gene expression in the neuropeptide Y system during ethanol withdrawal kindling in rats.
Olling JD; Ulrichsen J; Correll M; Woldbye DP
Alcohol Clin Exp Res; 2010 Mar; 34(3):462-70. PubMed ID: 20028355
[TBL] [Abstract][Full Text] [Related]
3. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
Sparrow AM; Lowery-Gionta EG; Pleil KE; Li C; Sprow GM; Cox BR; Rinker JA; Jijon AM; Peňa J; Navarro M; Kash TL; Thiele TE
Neuropsychopharmacology; 2012 May; 37(6):1409-21. PubMed ID: 22218088
[TBL] [Abstract][Full Text] [Related]
4. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse.
Thiele TE; Sparta DR; Hayes DM; Fee JR
Neuropeptides; 2004 Aug; 38(4):235-43. PubMed ID: 15337375
[TBL] [Abstract][Full Text] [Related]
5. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Ghrelin System in Drug Addiction.
Zallar LJ; Farokhnia M; Tunstall BJ; Vendruscolo LF; Leggio L
Int Rev Neurobiol; 2017; 136():89-119. PubMed ID: 29056157
[TBL] [Abstract][Full Text] [Related]
7. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats.
Caberlotto L; Thorsell A; Rimondini R; Sommer W; Hyytiä P; Heilig M
Alcohol Clin Exp Res; 2001 Nov; 25(11):1564-9. PubMed ID: 11707630
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
10. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure.
Ehlers CL; Li TK; Lumeng L; Hwang BH; Somes C; Jimenez P; Mathé AA
Alcohol Clin Exp Res; 1998 Nov; 22(8):1778-82. PubMed ID: 9835294
[TBL] [Abstract][Full Text] [Related]
12. Effects of drugs of abuse on the central neuropeptide Y system.
Gonçalves J; Martins J; Baptista S; Ambrósio AF; Silva AP
Addict Biol; 2016 Jul; 21(4):755-65. PubMed ID: 25904345
[TBL] [Abstract][Full Text] [Related]
13. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor.
Thiele TE; Koh MT; Pedrazzini T
J Neurosci; 2002 Feb; 22(3):RC208. PubMed ID: 11826154
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
Bhisikar SM; Kokare DM; Nakhate KT; Chopde CT; Subhedar NK
Life Sci; 2009 Nov; 85(21-22):765-72. PubMed ID: 19846044
[TBL] [Abstract][Full Text] [Related]
16. The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.
Schroeder JP; Overstreet DH; Hodge CW
Alcohol; 2005 Jul; 36(3):179-86. PubMed ID: 16377459
[TBL] [Abstract][Full Text] [Related]
17. Decreased gene expression of neuropeptide Y and its receptors in hippocampal regions during ethanol withdrawal in rats.
Olling JD; Ulrichsen J; Haugbøl S; Glenthøj B; Hemmingsen R; Woldbye DP
Neurosci Lett; 2007 Sep; 424(3):160-4. PubMed ID: 17723274
[TBL] [Abstract][Full Text] [Related]
18. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
Schroeder JP; Olive F; Koenig H; Hodge CW
Alcohol Clin Exp Res; 2003 Dec; 27(12):1884-91. PubMed ID: 14691375
[TBL] [Abstract][Full Text] [Related]
19. Central functions of neuropeptide Y in mood and anxiety disorders.
Wu G; Feder A; Wegener G; Bailey C; Saxena S; Charney D; Mathé AA
Expert Opin Ther Targets; 2011 Nov; 15(11):1317-31. PubMed ID: 21995655
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor.
Oki Y; Teraoka H; Kitazawa T
Auton Autacoid Pharmacol; 2017 Mar; 37(2):23-28. PubMed ID: 28544313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
